Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.
Pilar Pérez-GarcíaBárbara Burgos-BlascoVerónica Gómez-CallejaBeatriz Vidal-VillegasRosalía Méndez-FernándezJosé Antonio Gegúndez-FernándezDavid Díaz-VallePublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
The treatment with 5-fluorouracil is a good option as the second line of treatment for conjunctival intraepithelial neoplasia who are low-responders to interferon alpha-2b, with fewer side effects than other currently available alternatives.